Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week randomized, double-blind, placebo-controlled phase 2 trial of R7201/CSG452 in Japanese patients with type 2 diabetes mellitus
jRCT2080220828Phase 2
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tofogliflozin in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
tofogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220828.